News
EGRX
4.550
-4.61%
-0.220
Weekly Report: what happened at EGRX last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at EGRX last week (0408-0412)?
Weekly Report · 04/15 10:17
HROW, HCAT and EGRX are among after hour movers
On the Move HROW, HCAT and EGRX are among after hour movers. Eagle Pharmaceuticals (EGRX) is down 10%. Applied Optoelectronics (AAOI) and Harrow (HROW) are among the gainers.
Seeking Alpha · 04/12 21:05
Eagle Pharmaceuticals Risks Nasdaq Delisting Over Filing Delays
TipRanks · 04/12 20:34
Eagle Pharmaceuticals receives notification of deficiency from Nasdaq
Healthcare Eagle Pharmaceuticals receives notification of deficiency from Nasdaq. ETEagle Pharmaceuticals, Inc. (EGRX) Stock is not in compliance with continued listing requirements. Nasdaq says company failed to timely file its annual report for fiscal year ended December 31, 2023.
Seeking Alpha · 04/12 20:25
EAGLE PHARMACEUTICALS ANNOUNCES RECEIPT OF NOTIFICATION OF DEFICIENCY FROM NASDAQ REGARDING REQUIREMENT TO TIMELY FILE ANNUAL REPORT ON FORM 10-K
Reuters · 04/12 20:05
Weekly Report: what happened at EGRX last week (0401-0405)?
Weekly Report · 04/08 10:20
Weekly Report: what happened at EGRX last week (0325-0329)?
Weekly Report · 04/01 10:19
Weekly Report: what happened at EGRX last week (0318-0322)?
Weekly Report · 03/25 10:21
Weekly Report: what happened at EGRX last week (0311-0315)?
Weekly Report · 03/18 10:20
Eagle Pharmaceuticals announces resignation of Brian Cahill as CFO
Seeking Alpha · 03/11 16:01
Weekly Report: what happened at EGRX last week (0304-0308)?
Weekly Report · 03/11 10:18
Eagle Pharmaceuticals Announces CFO Transition and Leadership Changes
TipRanks · 03/08 22:03
Weekly Report: what happened at EGRX last week (0226-0301)?
Weekly Report · 03/04 10:20
Eagle Pharmaceut: Statement of changes in beneficial ownership of securities
Press release · 02/29 23:50
Eagle Pharmaceuticals to cut 36% of workforce
Healthcare Eagle Pharmaceuticals to cut 36% of workforce. The biopharma company said substantially all of the employees are connected to the commercialization of its drugs Byfavo, Barhemsys and Ryanodex. The company expects to incur charges of around $3.5M.
Seeking Alpha · 02/29 14:54
Weekly Report: what happened at EGRX last week (0219-0223)?
Weekly Report · 02/26 10:27
Weekly Report: what happened at EGRX last week (0212-0216)?
Weekly Report · 02/19 10:28
Eagle Pharmaceuticals Faces Nasdaq Delisting Deadline
TipRanks · 02/13 14:02
Weekly Report: what happened at EGRX last week (0205-0209)?
Weekly Report · 02/12 10:22
More
Webull provides a variety of real-time EGRX stock news. You can receive the latest news about Eagle Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About EGRX
Eagle Pharmaceuticals, Inc. is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial capabilities. The Company is focused on developing medicines that result in improvements in patients' lives. The Company's commercialized products include vasopressin, PEMFEXY, RYANODEX, BENDEKA, BELRAPZO, TREAKISYM (Japan), and BYFAVO and BARHEMSYS through its wholly owned subsidiary Acacia Pharma Inc. Its oncology and central nervous system (CNS)/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. The Company also has a research and development facility in Cambridge, Massachusetts. The Company has office space in Palm Beach Gardens, Florida and Indianapolis, Indiana. The Company’s subsidiaries include Eagle Biologics, Inc., Eagle Research Lab Limited, Acacia Pharma Group plc, Acacia Pharma Limited and Acacia Pharma Inc.